Navigation Links
New Studies Evaluating NexiumIn Pediatric GERD To Be Presented At,Annual Digestive Disease Week Meeting

AstraZeneca Focuses Research on Growing Childhood Condition

WASHINGTON, May 22, 2007 /PRNewswire-FirstCall/ -- AstraZeneca will present several studies today regarding pediatric patients with gastroesophageal reflux disease (GERD) during oral and poster sessions at the annual Digestive Disease Week meeting held at the Washington Convention Center.

The studies being presented further support AstraZeneca's commitment to research in the area of gastrointestinal health among the pediatric population. NEXIUM (esomeprazole magnesium) received approval in April 2006 for the short-term treatment (up to 8 weeks) of GERD in adolescent patients aged 12 to 17. The approval is supported by extrapolation of results from adequate and well-controlled studies that supported the approval of NEXIUM for adults, and safety and pharmacokinetic studies performed in adolescent patients. The safety and effectiveness of NEXIUM for the treatment of symptomatic GERD in patients less than 12 years of age and for other pediatric uses have not been established.

The exact prevalence of GERD in children is unknown. However, GERD can lead to potentially serious complications like failure to thrive and erosive esophagitis in children. There are very few studies in the medical literature reporting the frequency of GERD symptoms in children. One such study, a practice-based survey looked at the prevalence of GERD symptoms in 3-17 year old children. The study included 566 parents of otherwise healthy 3-9 year old children and revealed that symptoms of GERD (heartburn, epigastric pain and regurgitation) were reported weekly in 2-8%, which is not that uncommon.

"GERD, which can potentially lead to more serious conditions, not only impacts adults but it is also common in childhood," said Marta Illueca, MD, F.A.A.P., Director, Clinical Research, GI Respiratory, AstraZeneca. "With patient health being our priority, one of our object
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
4. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
5. Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
8. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
9. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
10. Eurands Zentase Effective in Treating Exocrine Pancreatic Insufficiency, Studies Show
11. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Post Your Comments:
(Date:8/1/2014)... 1, 2014 Research and Markets ... "Global Medical Biosensors Market 2014-2018" report to ... Medical biosensors are used to ... detectors. These biosensors monitor health status, disease betterment, ... methods. They are cost-effective and user-friendly devices. Also, ...
(Date:8/1/2014)... 1, 2014  NxStage Medical, Inc. (Nasdaq: NXTM ... that Jeffrey H. Burbank , Chief Executive Officer, and ... the 34 th Annual Canaccord Genuity Growth Conference being ... , on Wednesday, August 13 th at 4:30 p.m. ... at http://ir.nxstage.com/ .  About NxStage Medical ...
(Date:8/1/2014)... 2014 Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... are used to develop, manufacture and sell enzymes and ... industrial enzyme industries, announced today that it will report ... 30, 2014 after market close on Thursday, August 14, ... at 5:00 p.m. Eastern Time to discuss those results. ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 2Dyadic International To Announce Second Quarter 2014 Financial Results And Host Conference Call On Thursday, August 14, 2014 3
... Alere Inc. (NYSE: ALR ) ("Alere") announced ... totaling $2.1 billion.  Jefferies Finance LLC, GE Capital Markets, ... as joint lead arrangers for the credit facilities, and ... for the lenders under the credit facilities. ...
... Qmed.com , a UBM Canon publishing group brand ... directory and search engine, announced its supplier profiles are ... websites. This new search functionality allows medical device professionals ... paid listings) in search results when they conduct keyword ...
Cached Medicine Technology:Alere Inc. Announces $2.1 Billion Credit Facilities 2Qmed Profiles Searchable Across All Medical Device Websites 2Qmed Profiles Searchable Across All Medical Device Websites 3
(Date:8/1/2014)... Cannabis use among young people has spiked, ... 17 having used marijuana at least once and 17 percent ... ‘No’ to Drugs, Say ‘Yes to Life,’ volunteers from the ... this summer with factual information about drugs, to help reverse ... “Say ‘No’ to Drugs, Say ‘Yes’ to Life,” volunteers have ...
(Date:8/1/2014)... in regulating appetite and whole-body metabolism. A protein known ... food intake and body weight, but the identity of ... A new study in the Journal of ... type of neuron known as pro-opiomelanocortin (POMC) neurons is ... Sabrina Diano and colleagues at Yale University School of ...
(Date:8/1/2014)... 1, 2014 (HealthDay News) -- The U.S. Food and ... new drug, Jardiance, to help fight type 2 diabetes. ... added to existing treatment regimens to control blood sugar ... Rosebraugh, director of the Office of Drug Evaluation II ... said in an agency statement. The FDA also ...
(Date:8/1/2014)... Summer is here, and with it comes ... summer, and they can be a pain for dogs. Animal ... all their customers get rid of ticks and prevent them ... in the summer, which is why they are so active ... and woodland areas and carry a number of diseases, including ...
(Date:8/1/2014)... and the benefits of a cancer diagnosis may improve ... a study conducted by a researcher at the University ... an expressive writing intervention is the writing instruction. Otherwise, ... events. Writing a journal can be therapeutic, but oftentimes ... it,s effective or not," said Qian Lu, assistant professor ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Tis the Season for Tick Prevention 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3
... in rates between 2005 and 2007 , , THURSDAY, April 16 ... a hazard for U.S. workers, a new government report shows. ... employed adults declined overall between 1994 and 2007, there was ... to a report in the April 17 issue of ...
... cause and effect , , THURSDAY, April 16 (HealthDay News) ... A and C in their diet may be at increased ... of 40 studies conducted between 1980 and 2007 showed that ... vitamin A than those without the disease. The average intake ...
... Va., April 16 An African child dies every ... billion people become ill because of it. About 1 ... year from malaria -- a disease that is entirely ... Fund Senior Program Health Specialist David Shanklin stresses the ...
... Community Measurement issues second annual report on health care ... nationMINNEAPOLIS, April 16 Although the care provided to ... improved since the last report on eight of nine ... quality of care provided to patients on public health ...
... the infection, CDC warns, , , THURSDAY, April 16 (HealthDay ... that while rates of testing for sexually transmitted ... of young, sexually active U.S. women still do not ... Disease Control and Prevention combed through 2000-07 data reported ...
... has found that a painful pelvic affliction associated with ... prostatitis or chronic pelvic pain syndrome (CP/CPPS) is a ... genital pain. , This is the first study ... males, and to show the negative impact that pain, ...
Cached Medicine News:Health News:Lead Exposure in Workplace Still a Problem 2Health News:Low Vitamin A, C Intake Tied to Asthma Risk 2Health News:Every 30 Seconds an African Child Dies from Malaria; Education Key to Prevention 2Health News:Every 30 Seconds an African Child Dies from Malaria; Education Key to Prevention 3Health News:Several Minnesota Medical Groups Improve Care for Patients Served by Minnesota Health Care Programs, but Disparities Gap Remains 2Health News:Several Minnesota Medical Groups Improve Care for Patients Served by Minnesota Health Care Programs, but Disparities Gap Remains 3Health News:Less Than Half of Young Women Screened for Chlamydia 2Health News:Pelvic pain as prevalent in teens as older males, Queen's researchers discover 2
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... a complete offering of cardiology catheters. Available ... catheters are designed with excellent torque, new ... better push-ability, and large inner lumens for ... 6 and 7 French sizes with pressure ...
The Compass Commander series is engineered to provide the discriminating neurosurgeon with the same capabilities offered within the commander plus+, all in a smaller, lower-cost package....
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
Medicine Products: